Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma is a research paper published in PLoS Genetics (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
German Research Foundation
Grant: FE1746/1-1
Damon Runyon Cancer Research Foundation
Grant: DR52-18
Foundation for the National Institutes of Health
Grant: R37CA230636
U.S. Department of Defense
Grant: CA150272P2
National Institutes of Health
Grant: P30-CA196521
U.S. Department of Defense
Grant: CA150272P3
Horizon 2020
Grant: HEPCAR, Ref. 667273-2
EIT Health
Grant: CRISH2, Ref. 18053
Accelerator Award
Grant: HUNTER, Ref. C9380/A26813
Spanish National Health Institute
Grant: SAF2016-76390
Generalitat de Catalunya
Grant: SGR-1358
NCI NIH HHS
Grant: P30 CA196521
Cancer Research UK
Grant: 26813
European Commission
Grant: 667273
Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities.
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1P30CA196521-01
Mouse Genetics
National Institutes of Health
Grant: 4R37CA230636-06
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
Fundación Alfonso Martín Escudero
Foundation Roberto & Gianna Gonella
Swiss National Science Foundation
Asociación Española para el Estudio del Hígado
SICPA
Icahn School of Medicine at Mount Sinai
Samuel Waxman Cancer Research Foundation
FWCI
2.20
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals